FDA Warning Letter — Cohance Lifesciences Limited
The FDA took a Warning Letter action against Cohance Lifesciences Limited on January 30, 2026 (Medchal-Malkajgiri, India). The action was issued by CDER and concerns drugs products. This facility has 4 recent FDA inspections on record.
Action Details
- Facility
- Cohance Lifesciences Limited
- Date
- January 30, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Center
- CDER
- Location
- Medchal-Malkajgiri (India)